Evidence map›Paper›PMID 27298660›Full record

ArticleJournal of clinical medicine research2016

Toxoplasma gondii Infection and Mixed Anxiety and Depressive Disorder: A Case-Control Seroprevalence Study in Durango, Mexico.

Cosme Alvarado-Esquivel, Luis Francisco Sanchez-Anguiano, Jesus Hernandez-Tinoco, Luis Omar Berumen-Segovia, Yazmin Elizabeth Torres-Prieto, Sergio Estrada-Martinez, Alma Rosa Perez-Alamos, Maria Nalleli Ortiz-Jurado, Gabriel Molotla-de-Leon, Isabel Beristain Garcia and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of clinical medicine research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 3 pooled it
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 3 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Pregnant Women Chronically Infected byPathogens (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Global seroprevalence ofHealth science reports · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. IsPathogens (Basel, Switzerland) · 2021
    Article
  15. Association betweenPathogens (Basel, Switzerland) · 2021
    Article
  16. Examining the Relationship betweenPathogens (Basel, Switzerland) · 2021
    Article
  17. Association between Suicide andPathogens (Basel, Switzerland) · 2021
    Article
  18. Pathogens (Basel, Switzerland) · 2021
    Article
  19. Association betweenPathogens (Basel, Switzerland) · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Cosme Alvarado-EsquivelFaculty of Medicine and Nutrition, Juarez University of Durango State, Avenida Universidad S/N, 34000 Durango, Durango, Mexico.
Luis Francisco Sanchez-AnguianoInstitute for Scientific Research "Dr. Roberto Rivera Damm", Juarez University of Durango State, Avenida Universidad S/N, 34000 Durango, Durango, Mexico.
Jesus Hernandez-TinocoInstitute for Scientific Research "Dr. Roberto Rivera Damm", Juarez University of Durango State, Avenida Universidad S/N, 34000 Durango, Durango, Mexico.
Luis Omar Berumen-SegoviaFaculty of Medicine and Nutrition, Juarez University of Durango State, Avenida Universidad S/N, 34000 Durango, Durango, Mexico.
Yazmin Elizabeth Torres-PrietoFacultad de Enfermeria y Obstetricia, Juarez University of Durango State, Cuauhtemoc 223 Norte, 34000 Durango, Mexico.
Sergio Estrada-MartinezInstitute for Scientific Research "Dr. Roberto Rivera Damm", Juarez University of Durango State, Avenida Universidad S/N, 34000 Durango, Durango, Mexico.
Alma Rosa Perez-AlamosInstitute for Scientific Research "Dr. Roberto Rivera Damm", Juarez University of Durango State, Avenida Universidad S/N, 34000 Durango, Durango, Mexico.
Maria Nalleli Ortiz-JuradoHospital of Mental Health "Dr. Miguel Vallebueno", Servicios de Salud de Durango, Durango, Mexico.
Gabriel Molotla-de-LeonHospital of Mental Health "Dr. Miguel Vallebueno", Servicios de Salud de Durango, Durango, Mexico.
Isabel Beristain GarciaFacultad de Enfermeria y Obstetricia, Juarez University of Durango State, Cuauhtemoc 223 Norte, 34000 Durango, Mexico.
Elizabeth Rabago-SanchezFaculty of Medicine and Nutrition, Juarez University of Durango State, Avenida Universidad S/N, 34000 Durango, Durango, Mexico; General Hospital, Secretary of Health, Avenida 5 de febrero 220, 34000 Durango, Mexico.
Oliver LiesenfeldInstitute for Microbiology and Hygiene, Campus Benjamin Franklin, Charite Medical School, Hindenburgdamm 27, D-12203 Berlin, Germany; Current address: Roche Molecular Systems, Pleasanton, CA 94588, USA.
Universidad Juárez del Estado de Durango · MXCharité - Universitätsmedizin Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe parasite Toxoplasma gondii (T. gondii) may invade the brain and might induce behavioral changes. We sought to determine the association of T. gondii infection and mixed anxiety and depressive disorder.

methodsThrough an age- and gender-matched case-control seroprevalence study, we examined 65 patients suffering from mixed anxiety and depressive disorder (WHO ICD-10 code: F41.2) attending in a public hospital of mental health and 260 control subjects without this disorder from the general population. Sera of participants were analyzed for anti-Toxoplasma IgG and IgM antibodies using enzyme-linked immunoassays.

resultsFifteen (23.1%) of the 65 patients and 18 (6.9%) of the 260 controls had anti-T. gondii IgG antibodies (odds ratio (OR): 4.03; 95% confidence interval (CI): 1.90 - 8.53; P < 0.001). The frequency of high (> 150 IU/mL) anti-T. gondii IgG levels was similar in cases and controls (OR: 0.25; 95% CI: 0.05 - 1.06; P = 0.05). Seroprevalence was similar in male cases and controls (P = 1.0); however, seroprevalence was significantly higher in female cases than in female controls (OR: 7.08; 95% CI: 2.83 - 17.67; P < 0.00001). Patients aged 31 - 50 years old had a significantly higher seroprevalence of T. gondii infection than controls of the same age group (OR: 21.04; 95% CI: 5.22 - 84.80; P < 0.00001). Anti-T. gondii IgM antibodies were found in four (26.7%) of the 15 anti-T. gondii IgG seropositive cases and in 10 (55.6%) of the 18 anti-T. gondii IgG seropositive controls (P = 0.15).

conclusionsResults support for the first time an association between seropositivity to T. gondii and mixed anxiety and depressive disorder. Further research to confirm this association and to determine the seroepidemiology of T. gondii infection in patients with this disorder is needed.

Indexed as

Case-controlMixed anxiety and depressivePsychiatric patientsSeroprevalenceToxoplasma gondii

Identifiers

PMID27298660
PMCPMC4894021
OpenAlexW2394581761

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.